The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The Tylenol recall, which originally involved only the Tylenol arthritis pill, has now expanded to include Tylenol Extra Strength, Rolaids, and some children’s medicines, according to ABC News. Forbes is reporting the recall also includes Tylenol PM, Motrin IB, Benadryl, Simple Sleep, St. Joseph’s aspiring, etc.

This is one of the largest recalls in modern history with 60 million bottles recalled. It could affect thousands of people considering Tylenol pain relief tablets generated nearly $130 million in revenue (adjusted to 2003 dollars),according to BNET.

Reports indicate 70 percent of the people who’ve been exposed to these defective pills got sick due to the noxious odor or noticed the odor.

The problem appears to be the presence of a chemical known as 2,4,6-tribromoanisole (TBA), which forms after the breakdown of a chemical in wood pallets that are used to transport and store packaging materials for various drugs, including Tylenol.

The Food and Drug Administration (FDA) was critical of McNeil Healthcare LLC, the company which manufactures Tylenol, for their slow response to this growing problem.

"McNeil should have acted faster," said Deborah Autor, director of the FDA’s Office of Compliance. Mrs. Autor went on to say, “When something smells bad, literally or figuratively, companies must aggressively investigate.”

I agree with the FDA, especially considering McNeill received over 10 complaints about "musty-moldy odor" about Rolaids and nearly 40 complaints also referencing a foul odor about Tylenol Extra Strength, according to an FDA letter to McNeill.

About the Editors: Shapiro, Cooper, Lewis & Appleton personal injury law firm (NC-VA law offices ) edits the injury law blogs Northeast North Carolina Injuryboard, Virginia Beach Injuryboard, and Norfolk Injuryboard as a pro bono service to consumers.

Comments are closed.

Of Interest